BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7084816)

  • 21. Antihypertensive effect of indapamide.
    Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
    Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.
    Kim S; Hamaguchi A; Shinkawa T; Kato Y; Tsuchiya N; Miura K; Ohta K; Iwao H
    J Pharmacol Exp Ther; 1996 Nov; 279(2):983-90. PubMed ID: 8930208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.
    Narita H; Nagao T; Yabana H; Yamaguchi I
    J Pharmacol Exp Ther; 1983 Nov; 227(2):472-7. PubMed ID: 6631726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diuretic indapamide increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium.
    Lalande A; Roux C; Graulet AM; Schiavi P; De Vernejoul MC
    J Bone Miner Res; 1998 Sep; 13(9):1444-50. PubMed ID: 9738517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of prostaglandins in the mechanism of action of indapamide].
    Delbarre B; Delbarre G; Ferger A
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1209-12. PubMed ID: 2124458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology and clinical pharmacology of indapamide.
    Campbell DB; Moore RA
    Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of indapamide in resistant hypertensive therapy.
    Dean S
    Postgrad Med J; 1981; 57 Suppl 2():26-8. PubMed ID: 6119685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
    Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
    Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effect of trichlormethiazide in spontaneously hypertensive rats.
    Ueda M; Matsuda S; Tonda K; Matsunaga K
    Jpn J Pharmacol; 1978 Aug; 28(4):617-26. PubMed ID: 732042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antihypertensive effect of indapamide.
    Reyes AJ; Acosta-Barrios T; Leary WP; Van der Byl K
    S Afr Med J; 1983 May; 63(21):804-6. PubMed ID: 6845104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indapamide: a review.
    Reyes AJ; Leary WP
    S Afr Med J; 1983 Nov; Suppl():1-6. PubMed ID: 6356402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.